The inhibitory role of recombinant P-selectin glycoprotein ligand immunoglobulin G on portal vein thrombosis based on a novel rat model

scholarly article by Yunhai Wei et al published May 2019 in Experimental and Therapeutic Medicine

The inhibitory role of recombinant P-selectin glycoprotein ligand immunoglobulin G on portal vein thrombosis based on a novel rat model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3892/ETM.2019.7394
P932PMC publication ID6447773
P698PubMed publication ID30988741

P50authorYunhai WeiQ89160951
Lei YinQ124883216
P2093author name stringYan Wang
Jie Shao
Guoliang Cao
Hua Shen
Jinyu Zhang
Wenxian Chen
P2860cites workTime-dependent appearance of intrathrombus neutrophils and macrophages in a stasis-induced deep vein thrombosis model and its application to thrombus age determinationQ83299019
Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimationQ84561465
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Role of platelet P-selectin and microparticle PSGL-1 in thrombus formationQ28254159
New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-IgQ33341686
Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge.Q33393661
A multiscale model of venous thrombus formation with surface-mediated control of blood coagulation cascadeQ33820759
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse modelsQ34666946
Pro-coagulant state resulting from high levels of soluble P-selectin in bloodQ35578042
P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasisQ35848065
Selectins--potential pharmacological targets?Q36630618
Alterations of regional cerebral blood flow and oxygen saturation in a rat sinus-vein thrombosis modelQ36797343
Portal hypertension due to portal venous thrombosis: etiology, clinical outcomesQ36841714
Portal vein thrombosis: what is new?Q38299178
Thrombolytic therapy: current status (1).Q39640542
Portal vein thrombosis after splenectomyQ44253261
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosisQ46892092
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.Q47742048
P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfacesQ49238735
Evaluation of the Value of d-Dimer, P-Selectin, and Platelet Count for Prediction of Portal Vein Thrombosis After Devascularization.Q53632217
Portal vein thrombosisQ59105225
Failure of aspirin at different doses to modify experimental thrombosis in ratsQ59697802
P-Selectin-dependent inhibition of thrombosis during venous stasisQ73178321
P-selectin antagonism causes dose-dependent venous thrombosis inhibitionQ73768992
Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis modelQ74532531
P-selectin and PSGL-1: exploiting connections between inflammation and venous thrombosisQ77826981
P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat modelQ78489384
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectthrombosisQ261327
portal vein thrombosisQ1704044
B-scan ultrasonographyQ4833731
P304page(s)3589-3597
P577publication date2019-05-01
P1433published inExperimental and Therapeutic MedicineQ23979083
P1476titleThe inhibitory role of recombinant P-selectin glycoprotein ligand immunoglobulin G on portal vein thrombosis based on a novel rat model
P478volume17

Search more.